Literature DB >> 19375572

Trophoblast infection with Chlamydia pneumoniae and adverse pregnancy outcomes associated with placental dysfunction.

Luis M Gomez1, Samuel Parry.   

Abstract

OBJECTIVE: We sought to determine whether Chlamydia pneumoniae impairs invasive trophoblast function and is associated with preeclampsia. STUDY
DESIGN: We conducted cell viability and invasion assays using primary extravillous trophoblast cells isolated from first-trimester placentas. We performed a case-control study to identify C pneumoniae in trophoblast cells dissected by laser capture microscopy from placentas in women with severe preeclampsia and control subjects who delivered at term.
RESULTS: Trophoblast cell viability and invasion through extracellular matrices were decreased after infection with C pneumoniae (both P < .05). C pneumoniae DNA was detected in trophoblast cells in 15/48 cases but only 3/30 controls (odds ratio, 4.1; P = .02). Positive and negative controls yielded expected results.
CONCLUSION: C pneumoniae infection can reduce trophoblast invasion into the uterine wall and is associated with preeclampsia. Further investigation of the mechanisms by which C pneumoniae induces trophoblast dysfunction, and the identification of therapies to prevent adverse outcomes attributed to trophoblast dysfunction, are warranted.

Entities:  

Mesh:

Year:  2009        PMID: 19375572      PMCID: PMC2677073          DOI: 10.1016/j.ajog.2009.03.001

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  39 in total

1.  Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis.

Authors:  K Rajalingam; H Al-Younes; A Müller; T F Meyer; A J Szczepek; T Rudel
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

2.  Seroepidemiology in Chlamydia pneumoniae-- atherosclerosis association.

Authors:  P Saikku
Journal:  Eur Heart J       Date:  2002-02       Impact factor: 29.983

Review 3.  Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

Authors:  S F Dowell; R W Peeling; J Boman; G M Carlone; B S Fields; J Guarner; M R Hammerschlag; L A Jackson; C C Kuo; M Maass; T O Messmer; D F Talkington; M L Tondella; S R Zaki
Journal:  Clin Infect Dis       Date:  2001-07-20       Impact factor: 9.079

4.  Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance.

Authors:  Franz-Josef Neumann
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

5.  Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity.

Authors:  Dirk Sander; Kerstin Winbeck; Jürgen Klingelhöfer; Thorleif Etgen; Bastian Conrad
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

Review 6.  Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.

Authors:  J T Grayston
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

7.  Enhanced progression of early carotid atherosclerosis is related to Chlamydia pneumoniae (Taiwan acute respiratory) seropositivity.

Authors:  D Sander; K Winbeck; J Klingelhöfer; T Etgen; B Conrad
Journal:  Circulation       Date:  2001-03-13       Impact factor: 29.690

8.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors:  P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

Review 9.  Chlamydia pneumoniae and atherosclerosis.

Authors:  Y K Wong; P J Gallagher; M E Ward
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

10.  Seroprevalence of antibodies to Chlamydia pneumoniae in women with preeclampsia.

Authors:  R Phillip Heine; Roberta B Ness; James M Roberts
Journal:  Obstet Gynecol       Date:  2003-02       Impact factor: 7.661

View more
  8 in total

Review 1.  Pathogens and the placental fortress.

Authors:  Jennifer R Robbins; Anna I Bakardjiev
Journal:  Curr Opin Microbiol       Date:  2011-12-12       Impact factor: 7.934

2.  Low-Dose Aspirin May Prevent Trophoblast Dysfunction in Women With Chlamydia Pneumoniae Infection.

Authors:  Luis M Gomez; Lauren Anton; Shindu K Srinivas; Michal A Elovitz; Samuel Parry
Journal:  Reprod Sci       Date:  2018-12-20       Impact factor: 3.060

3.  Prenatal Chlamydia trachomatis infection increases the risk of preeclampsia.

Authors:  Catherine L Haggerty; Mark A Klebanoff; Inge Panum; Soren A Uldum; Debra C Bass; Jorn Olsen; James M Roberts; Roberta B Ness
Journal:  Pregnancy Hypertens       Date:  2013-07-01       Impact factor: 2.899

4.  Nod1, but not the ASC inflammasome, contributes to induction of IL-1β secretion in human trophoblasts after sensing of Chlamydia trachomatis.

Authors:  P B Kavathas; C M Boeras; M J Mulla; V M Abrahams
Journal:  Mucosal Immunol       Date:  2012-07-04       Impact factor: 7.313

Review 5.  Human infectious diseases and risk of preeclampsia: an updated review of the literature.

Authors:  Malihe Nourollahpour Shiadeh; Zahra Behboodi Moghadam; Ishag Adam; Vafa Saber; Maryam Bagheri; Ali Rostami
Journal:  Infection       Date:  2017-06-02       Impact factor: 3.553

6.  Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father.

Authors:  Louise C Kenny; Douglas B Kell
Journal:  Front Med (Lausanne)       Date:  2018-01-04

7.  Brucella abortus Infection of Placental Trophoblasts Triggers Endoplasmic Reticulum Stress-Mediated Cell Death and Fetal Loss via Type IV Secretion System-Dependent Activation of CHOP.

Authors:  Mariana X Byndloss; April Y Tsai; Gregory T Walker; Cheryl N Miller; Briana M Young; Bevin C English; Núbia Seyffert; Tobias Kerrinnes; Maarten F de Jong; Vidya L Atluri; Maria G Winter; Jean Celli; Renée M Tsolis
Journal:  mBio       Date:  2019-07-23       Impact factor: 7.867

8.  Perinatal Outcomes Among Patients With Sepsis During Pregnancy.

Authors:  Christine A Blauvelt; Kiana C Nguyen; Arianna G Cassidy; Stephanie L Gaw
Journal:  JAMA Netw Open       Date:  2021-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.